AngioDynamics to Hold Fiscal 2010 First Quarter Financial Results Conference Call on October 6, 2009QUEENSBURY, N.Y.--(BUSINESS WIRE)--Sep. 21, 2009--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative
medical devices used by interventional radiologists and surgeons for the
minimally-invasive treatment of cancer and peripheral vascular disease,
announced today that it will report its fiscal 2010 first quarter
financial results on
Tuesday, October 6, 2009, after the close of the
financial markets.
Jan Keltjens, President and Chief Executive Officer, and Joseph Gersuk,
Executive Vice President and CFO, will host an investment community
conference call beginning at 4:30 p.m. Eastern time on October 6 to
discuss these results and to answer questions.
To participate in the live call by telephone, please dial +1 (877)
941-1848 from the U.S., or for international callers, please dial +1
(480) 629-9722.
Those interested in listening to the conference call live via the
Internet may do so by visiting the Investor Relations section of
AngioDynamics’ Web site at http://investor.angiodynamics.com.
To listen to the live call, please go to the Web site 15 minutes prior
to its start to register, download and install the necessary audio
software.
A replay will be available on the Web site. A telephone replay will be
available from 6:30 p.m. Eastern time on October 6, 2009, through 11:59
p.m. Eastern time on October 13 by dialing +1 (800) 406-7325 (domestic)
or +1 (303) 590-3030 (international) and entering the passcode: 4159408#.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons and other physicians for
the minimally-invasive treatment of cancer and peripheral vascular
disease. The Company’s diverse product line includes market-leading
radiofrequency and irreversible electroporation ablation systems,
vascular access products, angiographic products and accessories,
dialysis products, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
Source: AngioDynamics, Inc.
AngioDynamics, Inc.
D. Joseph Gersuk, CFO,
800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC
Group, Inc.
Investors:
Doug Sherk, 415-896-6820
dsherk@evcgroup.com
Jenifer
Kirtland, 415-896-6820
jkirtland@evcgroup.com
Media:
Chris
Gale, 646-201-5431
cgale@evcgroup.com
